HUT46920A - Process for producing acyl derivatives - Google Patents

Process for producing acyl derivatives

Info

Publication number
HUT46920A
HUT46920A HU881705A HU170588A HUT46920A HU T46920 A HUT46920 A HU T46920A HU 881705 A HU881705 A HU 881705A HU 170588 A HU170588 A HU 170588A HU T46920 A HUT46920 A HU T46920A
Authority
HU
Hungary
Prior art keywords
acyl derivatives
producing acyl
producing
derivatives
acyl
Prior art date
Application number
HU881705A
Other languages
English (en)
Other versions
HU201948B (en
Inventor
Andre Furlenmeier
Erwin Goetschi
Paul Hebeisen
Werner Hofheinz
Helmut Link
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HUT46920A publication Critical patent/HUT46920A/hu
Publication of HU201948B publication Critical patent/HU201948B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
HU881705A 1987-04-10 1988-04-06 Process for producing cefemcarboxylic acid derivatives and pharmaceutical compositions comprising same HU201948B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH140787 1987-04-10
CH165787 1987-04-30
CH241487 1987-06-26

Publications (2)

Publication Number Publication Date
HUT46920A true HUT46920A (en) 1988-12-28
HU201948B HU201948B (en) 1991-01-28

Family

ID=27172952

Family Applications (1)

Application Number Title Priority Date Filing Date
HU881705A HU201948B (en) 1987-04-10 1988-04-06 Process for producing cefemcarboxylic acid derivatives and pharmaceutical compositions comprising same

Country Status (15)

Country Link
US (1) US5055572A (hu)
EP (1) EP0286144A3 (hu)
JP (1) JPH01261392A (hu)
KR (1) KR880012611A (hu)
AU (1) AU611428B2 (hu)
DK (1) DK170088A (hu)
FI (1) FI881641A (hu)
HU (1) HU201948B (hu)
IL (1) IL85970A0 (hu)
MC (1) MC1920A1 (hu)
NO (1) NO881530L (hu)
NZ (1) NZ224130A (hu)
PH (1) PH24960A (hu)
PT (1) PT87202B (hu)
YU (1) YU70888A (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
NZ225383A (en) * 1987-08-07 1990-03-27 Sankei Yakuhin Kk Cephalosporin derivatives and pharmaceutical compositions
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
DE3939533A1 (de) * 1989-11-30 1991-06-06 Bayer Ag Neue cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
GB201111705D0 (en) * 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
WO2013073577A1 (ja) 2011-11-15 2013-05-23 アステラス製薬株式会社 ジヒドロキシ芳香族へテロ環化合物
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
CN110655526A (zh) * 2018-06-28 2020-01-07 中国科学院上海药物研究所 头孢菌素-铁载体轭合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
AU586215B2 (en) * 1985-01-21 1989-07-06 Nippon Pharmaceutical Development Institute Company Limited Novel ```-lactam antibiotics
AU586229B2 (en) * 1985-04-01 1989-07-06 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives

Also Published As

Publication number Publication date
DK170088D0 (da) 1988-03-28
PT87202B (pt) 1992-07-31
US5055572A (en) 1991-10-08
MC1920A1 (fr) 1989-04-06
AU1431088A (en) 1988-10-13
DK170088A (da) 1988-10-11
PH24960A (en) 1990-12-26
AU611428B2 (en) 1991-06-13
FI881641A (fi) 1988-10-11
HU201948B (en) 1991-01-28
JPH01261392A (ja) 1989-10-18
EP0286144A2 (de) 1988-10-12
EP0286144A3 (de) 1990-10-03
NZ224130A (en) 1991-02-26
PT87202A (pt) 1988-05-01
NO881530L (no) 1988-10-11
IL85970A0 (en) 1988-09-30
NO881530D0 (no) 1988-04-08
FI881641A0 (fi) 1988-04-08
KR880012611A (ko) 1988-11-28
YU70888A (en) 1989-12-31

Similar Documents

Publication Publication Date Title
HU208147B (en) Process for producing etoposide-aminophosphate derivatives
HUT46919A (en) Process for producing acyl derivatives
HUT47644A (en) Process for producing avermeklin b derivatives
HUT46672A (en) Process for producing 9-amino-tetrahydroacridine derivatives
YU130288A (en) Process for obtaining benzopirane derivatives
HU46335A (en) Process for producing 4-demethoxy-4-amino-anthracycline derivatives
HUT48245A (en) Process for producing imidazo-pyridin derivatives
HUT48684A (en) Process for producing avermektin derivatives
HUT47944A (en) Process for producing acyl derivatives
HUT45241A (en) Process for producing naphthothiazepinone derivatives
YU152188A (en) Process for obtaining new aminoalcoxiphenyl derivatives
HUT46029A (en) Process for producing inosose derivatives
HUT46668A (en) Process for producing pyridine derivatives
YU55088A (en) Process for obtaining propylolephine derivatives
HUT46920A (en) Process for producing acyl derivatives
YU198989A (en) Process for obtaining quinolynic derivatives
EP0268820A3 (en) Process for producing 2-acylfuran derivatives
HUT49854A (en) Process for producing 5-amino-1-phenyl-4-nitropyrazole derivatives
HUT52489A (en) Process for producing cycloalkyl-thiazol derivatives
HUT53360A (en) Process for producing benzoxazolon derivatives
YU207888A (en) Process for obtaining new cistaine derivatives
HUT47120A (en) Process for producing acyl derivatives
HUT48639A (en) Process for producing 4-demetoxy-antracyclin derivatives
HUT46035A (en) Process for producing 16-dehydro-20-oxopregnane derivatives
YU110888A (en) Process for obtaining timine derivatives

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee